Suppr超能文献

人类高血压中利尿剂诱发低钾血症的机制。

Mechanism of diuretic-induced hypopotassemia in human hypertension.

作者信息

Kezdi P, Danopulos D, Stanley E L, Mullins M

出版信息

Klin Wochenschr. 1985;63 Suppl 3:125-8.

PMID:2987608
Abstract

Diuretic treatment (hydrochlorothiazide) induced a marked decrease of red cell membrane Na+K+ ATPase activity in excessive potassium loser hypertensive patients. The decreased activity occurred within 2-4 weeks of treatment and returned to baseline in 4-6 weeks after cessation of treatment. Simultaneously, red cell sodium increased, potassium decreased together with increased 24-h urinary excretion. The persistent low serum potassium may be due to impaired absorption of potassium from the gut as a result of suppressed enzyme activity since total body potassium appears also to decrease. The decreased Na+K+ ATPase activity may be due to a direct effect of the diuretic on cell membrane.

摘要

利尿剂治疗(氢氯噻嗪)导致钾过度流失的高血压患者红细胞膜钠钾ATP酶活性显著降低。活性降低在治疗的2 - 4周内出现,并在停药后4 - 6周恢复至基线水平。同时,红细胞钠增加,钾减少,24小时尿排泄量增加。持续性低血钾可能是由于酶活性受抑制导致肠道钾吸收受损,因为总体钾似乎也在减少。钠钾ATP酶活性降低可能是利尿剂对细胞膜的直接作用所致。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验